Cognitive impairment observed in central nervous system diseases suggests that BDNF may be a potential biomarker candidate as its effect has been implicated in learning and memory (Guo et al., 2015; Zhang et al., 2015). The gene discussed is BDNF; the disease is central nervous system disorder.